SEC Filing Summary: SES AI Corp (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by SES AI Corporation on September 26, 2024. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the continued listing status of the Company's Class A common stock (trading symbol: SES) and warrants (trading symbol: SES WS).
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on compliance with listing standards. The specific financial metric triggering this report is the stock price performance: the average closing price of the Class A common stock was less than $1.00 over a consecutive 30 trading-day period.
Material Changes and Listing Status
- Non-Compliance Notice: The Company was notified by the NYSE of non-compliance with Section 802.01C of the NYSE Listed Company Manual due to the low average closing share price.
- Immediate Effect: The notice does not result in immediate delisting. The stock will continue to trade on the NYSE during the cure period.
- Cure Period: The Company has a six-month period following the receipt of the notice to regain compliance.
- Compliance Criteria: To regain compliance, the Company must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of any calendar month within the cure period.
Guidance, Outlook, and Risks
Management intends to notify the NYSE of its intent to regain compliance and is considering available alternatives, which may include actions requiring stockholder approval, such as a reverse stock split. If a reverse stock split is pursued, the price condition is deemed cured if the price promptly exceeds $1.00 per share and remains above that level for at least 30 trading days.
The filing includes forward-looking statements regarding the ability to maintain the listing and cure the deficiency. Risks include the inability to regain compliance within the cure period, continued volatility of the stock and warrants, and other risks detailed in the Company's 2023 Form 10-K.
Investor Verification Checklist
- Verify the current trading price and 30-day average of SES Class A common stock to assess proximity to the $1.00 threshold.
- Monitor upcoming press releases or filings for announcements regarding a potential reverse stock split or other capital structure changes.
- Review the Company's 2023 Form 10-K for detailed risk factors related to stock price volatility and delisting.
- Track the NYSE's continued listing standards to understand the specific timeline for the six-month cure period.